TOVX insider filings
Theriva Biologics, Inc. — 24 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-01-06. Screen TOVX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for TOVX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Theriva Biologics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-06 | 4 | Wolf Jeffrey Alan — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Kraws Jeffrey J — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | SHALLCROSS STEVEN A — CEO and CFO, Director | Grant/award (A): 475,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | MONAHAN JOHN J — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Wolf Jeffrey Alan — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Kraws Jeffrey J — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | SHALLCROSS STEVEN A — CEO and CFO, Director | Grant/award (A): 190,000 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | MONAHAN JOHN J — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-12-15 | 4 | Wolf Jeffrey Alan — Director | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2023-12-15 | 4 | Kraws Jeffrey J — Director | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2023-12-15 | 4 | SHALLCROSS STEVEN A — CEO and CFO, Director | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2023-12-15 | 4 | MONAHAN JOHN J — Director | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | SHALLCROSS STEVEN A — CEO and CFO, Director | Purchase (P): 14,000 @ $0.69 | EDGAR |
| 2023-06-07 | 4 | SHALLCROSS STEVEN A — CEO and CFO, Director | Purchase (P): 26,000 @ $0.63 | EDGAR |
| 2023-02-13 | 4 | SHALLCROSS STEVEN A — CEO and CFO, Director | Purchase (P): 25,000 @ $1.04 | EDGAR |
| 2023-02-03 | 4 | SHALLCROSS STEVEN A — CEO and CFO, Director | Purchase (P): 25,000 @ $0.94 | EDGAR |
| 2023-01-26 | 4 | SHALLCROSS STEVEN A — CEO and CFO, Director | Purchase (P): 25,000 @ $0.87 | EDGAR |
| 2023-01-23 | 4 | SHALLCROSS STEVEN A — CEO and CFO, Director | Purchase (P): 25,000 @ $0.75 | EDGAR |
| 2023-01-03 | 4 | SHALLCROSS STEVEN A — CEO and CFO, Director | Purchase (P): 100,000 @ $0.44 | EDGAR |
| 2022-12-16 | 4 | Tufaro Francis — Chief Operating Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-12-16 | 4 | Wolf Jeffrey Alan — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-12-16 | 4 | Kraws Jeffrey J — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-12-16 | 4 | SHALLCROSS STEVEN A — CEO and CFO, Director | Grant/award (A): 475,000 (derivative) @ $0 | EDGAR |
| 2022-12-16 | 4 | MONAHAN JOHN J — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Theriva Biologics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-20 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-18 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TOVX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs